• about us
  • allosteric modulation
  • pipeline
  • key indications
  • business development
  • investor center
  • press releases
    • webcasts & presentations
    • media contact
  • careers
  • contact

press releases

home > press releases
  • All categories
    • 2010
    • 2009
    • 2008
    • 2007
    • 2006
    • 2005
    • 2004
    • 2003
    • 2002
Sep 22 Addex Pharmaceuticals Initiates Phase I Trials with ADX10059, a novel compound intended for Anxiety and Migraine
Jan 26 Addex Pharmaceuticals named by tornado insider among europe's top 100 private tech companies
Jan 17 Addex Pharmaceuticals enters into Collaboration with Ortho-McNeil Pharmaceutical to Develop Novel Treatments for Anxiety, Depression, Schizophrenia and Alzheimer's disease

home | contact | sitemap | impressum

© 2010, ADDEX Pharmaceuticals